MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Country |
 USA |
IPO year |
1991 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
80.4 M |
Market Cap[1] |
$ 50.9 B |
EBITDA (LTM) |
$ 1.32 B |
P/E (LTM) |
51.07 |
P/S (LTM) |
12.65 |
EPS (LTM) |
12.9 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 118.03 | -2.76 % | $ 35.9 B | NYSE,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Biodesix
BDSX
|
$ 15.41 | 0.49 % | $ 2 B | Nasdaq Global Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.14 | -0.95 % | $ 1.45 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 26.33 | 0.3 % | $ 279 M | Nasdaq Global Market |  China |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.52 | -3.02 % | $ 534 M | Nasdaq Global Select Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 24.16 | 4.39 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 18.89 | 0.69 % | $ 1.01 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 107.94 | -3.37 % | $ 4.26 B | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Charles River Laboratories International
CRL
|
$ 177.86 | -0.35 % | $ 8.82 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 29.24 | -1.12 % | $ 812 M | Nasdaq Global Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 212.36 | 0.21 % | $ 23.6 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 206.08 | -2.16 % | $ 147 B | NYSE,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 11.3 | -5.6 % | $ 321 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 72.71 | -0.98 % | $ 28.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.32 | -0.06 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 14.61 | -4.7 % | $ 442 M | Nasdaq Global Market | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Guardant Health
GH
|
$ 91.72 | -2.33 % | $ 11.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 109.51 | 1.26 % | $ 9.03 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 132.06 | -1.78 % | $ 21 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 174.73 | -2.28 % | $ 30 B | NYSE,SPB | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 285.7 | -1.18 % | $ 23.8 B | NYSE,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Lantheus Holdings
LNTH
|
$ 76.92 | 2.68 % | $ 5.19 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 449.18 | -0.57 % | $ 13 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 331.55 | -2.57 % | $ 27.4 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.98 | 8.03 % | $ 461 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 3.83 | -7.71 % | $ 2.06 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 9.46 | -3.76 % | $ 1.21 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.02 | -1.87 % | $ 2.39 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 14.16 | 5.59 % | $ 347 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 199.25 | -4.23 % | $ 19.6 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.19 | -0.72 % | $ 826 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.63 | -2.96 % | $ 489 M | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.